Sarcoidosis is a multisystemic disorder of unknown cause characterized by the formation of immune granulomas in involved organs.
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 1, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 1, 2026
The limited documentation surrounding sarcoidosis reflects its rarity and the complexity of its clinical presentation. Because this condition affects fewer than 5 in 10,000 people, systematic studies have been challenging to conduct. Additionally, the variability in symptoms and the overlap with other diseases complicate the characterization of its clinical features. Ongoing research may provide more clarity in the future.
To navigate your sarcoidosis journey, consider consulting a pulmonologist with expertise in interstitial lung diseases, as sarcoidosis often affects the lungs. Additionally, genetic counseling may be beneficial given the involvement of the NOD2 gene. While there are no specific patient organizations identified for sarcoidosis, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support. Engaging in clinical trials may also be an option to explore.
Currently, there are 75 active clinical trials investigating various aspects of sarcoidosis. These trials may explore new treatment options, diagnostic methods, or the disease's natural history. For more information on these trials, you can visit the ClinicalTrials.gov search page for sarcoidosis: https://clinicaltrials.gov/search?cond=sarcoidosis. This research offers hope for better understanding and management of the condition.
Actionable guidance for navigating care for sarcoidosis
To navigate your sarcoidosis journey, consider consulting a pulmonologist with expertise in interstitial lung diseases, as sarcoidosis often affects the lungs. Additionally, genetic counseling may be beneficial given the involvement of the NOD2 gene. While there are no specific patient organizations identified for sarcoidosis, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support. Engaging in clinical trials may also be an option to explore.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 1, 2026
Consider asking your healthcare providers these condition-specific questions
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning sarcoidosis
Updated Feb 6, 2026
Priovant reports positive results from the Phase 2 BEACON study of Brepocitinib for cutaneous sarcoidosis, marking a significant step as the first industry-sponsored placebo-controlled trial in this area. The company is now preparing to advance to Phase 3 trials.
Recent research published in PubMed outlines the disease mechanisms, diagnostic pathways, and treatment options for sarcoidosis. This comprehensive review enhances understanding of the condition, which may aid in improving patient management.